KR930700550A - 인터류킨-6조성물 및 그 제조법 - Google Patents
인터류킨-6조성물 및 그 제조법Info
- Publication number
- KR930700550A KR930700550A KR1019920703255A KR920703255A KR930700550A KR 930700550 A KR930700550 A KR 930700550A KR 1019920703255 A KR1019920703255 A KR 1019920703255A KR 920703255 A KR920703255 A KR 920703255A KR 930700550 A KR930700550 A KR 930700550A
- Authority
- KR
- South Korea
- Prior art keywords
- human interleukin
- interleukin
- manufacturing
- composition
- composition containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 102000004889 Interleukin-6 Human genes 0.000 title 1
- 108090001005 Interleukin-6 Proteins 0.000 title 1
- 229940100601 interleukin-6 Drugs 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 101001076408 Homo sapiens Interleukin-6 Proteins 0.000 abstract 5
- 229940116886 human interleukin-6 Drugs 0.000 abstract 5
- 238000000034 method Methods 0.000 abstract 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- 125000000837 carbohydrate group Chemical group 0.000 abstract 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 abstract 1
- 229960005070 ascorbic acid Drugs 0.000 abstract 1
- 235000010323 ascorbic acid Nutrition 0.000 abstract 1
- 239000011668 ascorbic acid Substances 0.000 abstract 1
- 238000004587 chromatography analysis Methods 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 229960002897 heparin Drugs 0.000 abstract 1
- 229920000669 heparin Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/204—IL-6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5412—IL-6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0656—Adult fibroblasts
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Wood Science & Technology (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Immunology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8660291 | 1991-04-18 | ||
| JP8828491 | 1991-04-19 | ||
| PCT/JP1992/000487 WO1992018537A1 (en) | 1991-04-18 | 1992-04-17 | Interleukin 6 composition and production thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR930700550A true KR930700550A (ko) | 1993-03-15 |
Family
ID=26427716
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019920703255A Withdrawn KR930700550A (ko) | 1991-04-18 | 1992-12-16 | 인터류킨-6조성물 및 그 제조법 |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0550756B1 (enExample) |
| KR (1) | KR930700550A (enExample) |
| AT (1) | ATE210150T1 (enExample) |
| AU (1) | AU1554592A (enExample) |
| CA (1) | CA2085744A1 (enExample) |
| DE (1) | DE69232259T2 (enExample) |
| ES (1) | ES2164050T3 (enExample) |
| FI (1) | FI925745A0 (enExample) |
| TW (1) | TW221379B (enExample) |
| WO (1) | WO1992018537A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5338834A (en) * | 1993-01-26 | 1994-08-16 | Allelix Biopharmaceuticals Inc. | Ultrapure human interleukin-6 |
| AU2051899A (en) | 1997-12-03 | 1999-06-16 | Roche Diagnostics Gmbh | Method for preparing polypeptides with appropriate glycosilation |
| IL143641A0 (en) | 1998-12-09 | 2002-04-21 | A method for manufacturing glycoproteins having human-type glycosylation | |
| DE60035285T2 (de) | 1999-10-26 | 2008-02-21 | Plant Research International B.V. | Glykolisierung des säugetiertyps in pflanzen |
| WO2002057468A2 (en) | 2001-01-19 | 2002-07-25 | The Dow Chemical Company | Method for secretory production of glycoprotein having human-type sugar chain using plant cell |
| JP4532118B2 (ja) | 2002-03-19 | 2010-08-25 | スティヒティング ディーンスト ランドバウクンディフ オンデルズーク | 植物体内のグリカンプロセシングの最適化 |
| EP2319934B1 (en) | 2002-03-19 | 2015-09-02 | Stichting Dienst Landbouwkundig Onderzoek | GnTIII (UDP-N-acetylglucosamine:Beta -D mannoside Beta (1,4)-N-acetylglucosaminyltransferase III) expression in plants. |
| CL2003002461A1 (es) | 2002-11-27 | 2005-01-07 | Dow Chemical Company Agroscien | Inmunoglobulina que comprende al menos un glicano afucosilado, composicion que la contiene, secuencia nucleotidica y vector que la comprende, procedimiento para producir dicha inmunoglobulina en plantas. |
| EP2535418B1 (en) | 2007-04-17 | 2016-03-30 | Stichting Dienst Landbouwkundig Onderzoek | Mammalian-type glycosylation in plants by expression of non-mammalian glycosyltransferases |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6062997A (ja) * | 1983-09-17 | 1985-04-11 | Mochida Pharmaceut Co Ltd | インタ−フエロンの生産方法 |
| DE3519011A1 (de) * | 1985-05-25 | 1986-11-27 | Behringwerke Ag, 3550 Marburg | Verfahren zur herstellung eines materials zur affinitaetschromatographie |
| JPS62153755A (ja) * | 1985-12-27 | 1987-07-08 | Showa Denko Kk | クロマトグラフイ−用吸着担体 |
| JP2648860B2 (ja) * | 1986-05-08 | 1997-09-03 | イエダ リサーチ アンド デベロップメント コンパニー リミテッド | ヒトインターフエロン−β２Ａ及びヒトインターフエロン−β２Ｂ、該インターフエロンをコードする遺伝子を含むベクター、該インターフエロンを産生するセルライン及び該インターフエロンの医薬品としての用途 |
| IE67035B1 (en) * | 1986-07-08 | 1996-02-21 | Genetics Inst | Production and use of non-glycosylated IL-6 |
| JP2676336B2 (ja) * | 1986-08-06 | 1997-11-12 | 忠三 岸本 | ヒトｂ細胞分化因子の遺伝子 |
| JPS63150297A (ja) * | 1986-12-12 | 1988-06-22 | Ajinomoto Co Inc | 新規ｂ細胞分化因子蛋白標品 |
| ATE112308T1 (de) * | 1987-10-13 | 1994-10-15 | Thomae Gmbh Dr K | Verfahren zur herstellung von proteinen. |
| JPH03133935A (ja) * | 1989-10-19 | 1991-06-07 | Toray Ind Inc | ヒト天然型インターロイキン６組成物 |
-
1992
- 1992-04-17 AT AT92908258T patent/ATE210150T1/de not_active IP Right Cessation
- 1992-04-17 WO PCT/JP1992/000487 patent/WO1992018537A1/ja not_active Ceased
- 1992-04-17 FI FI925745A patent/FI925745A0/fi not_active Application Discontinuation
- 1992-04-17 EP EP92908258A patent/EP0550756B1/en not_active Expired - Lifetime
- 1992-04-17 DE DE69232259T patent/DE69232259T2/de not_active Expired - Fee Related
- 1992-04-17 CA CA002085744A patent/CA2085744A1/en not_active Abandoned
- 1992-04-17 AU AU15545/92A patent/AU1554592A/en not_active Abandoned
- 1992-04-17 ES ES92908258T patent/ES2164050T3/es not_active Expired - Lifetime
- 1992-04-30 TW TW081103408A patent/TW221379B/zh active
- 1992-12-16 KR KR1019920703255A patent/KR930700550A/ko not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| DE69232259T2 (de) | 2002-06-13 |
| FI925745L (fi) | 1992-12-17 |
| AU1554592A (en) | 1992-11-17 |
| ES2164050T3 (es) | 2002-02-16 |
| FI925745A7 (fi) | 1992-12-17 |
| FI925745A0 (fi) | 1992-12-17 |
| WO1992018537A1 (en) | 1992-10-29 |
| TW221379B (enExample) | 1994-03-01 |
| DE69232259D1 (de) | 2002-01-17 |
| CA2085744A1 (en) | 1992-10-19 |
| EP0550756B1 (en) | 2001-12-05 |
| EP0550756A1 (en) | 1993-07-14 |
| ATE210150T1 (de) | 2001-12-15 |
| EP0550756A4 (enExample) | 1994-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI880845L (fi) | bFGF:n muteiinia koodaava DNA, mainittua DNA:ta sisältävä transformoitu bakteeri ja menetelmä muteiinin tuottamiseksi | |
| FI881139A7 (fi) | Karkaistun ja/tai taivutetun, hopeakerroksen sisältävän lasilevyn valmistusmenetelmä, menetelmän mukaan valmistettu lasilevy ja tämän käyttö | |
| LU91498I2 (fr) | Etanercept et ses dérivés pharmaceutiquement acceptables. | |
| IL87832A0 (en) | Apparatus for the intensive,controlled production of microorganisms by photosynthesis | |
| DE3688009D1 (de) | Verfahren zum herstellen von kieselsaeure hoher reinheit. | |
| KR930700550A (ko) | 인터류킨-6조성물 및 그 제조법 | |
| ATE87335T1 (de) | Methode fuer selektiven zuwachs des anteils der gewoenlichen hauptkomponente des antibiotischen komplexes a/16686. | |
| DE3873988D1 (de) | Mikroporoeses membran-rieselbettverfahren. | |
| DE3481515D1 (de) | Anthracyclin-derivate, ein mikrobiologisches verfahren zu ihrer herstellung und ihre verwendung als cytostatika. | |
| FI915402A7 (fi) | Koostumus ja menetelmä a-D-galaktosidisitoutuneiden tai sitä sisältävi en sokereiden aiheuttamien maha- ja suolistovaivojen vähentämiseksi | |
| DE3675714D1 (de) | Substituierte hexahydroarylchinolizinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| DE68919282D1 (de) | Verfahren zur Herstellung von Cephalosporin und Zwischenverbindungen. | |
| DE3583780D1 (de) | 2,3-dihydro-1h-inden-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| KR950700684A (ko) | 시클릭 항-종양 촉진제 화합물, 그의 조성물, 제조 방법 및 용도(Cyclic Anti-Tumor Promoter Compounds, Compositions and Methods for Production and Use) | |
| IT8124094A0 (it) | Dispositivo per la produzione di pezzi da lavorare per mezzo di presso-fusione o presso-iniezione. | |
| ATE81495T1 (de) | Verfahren zur herstellung von natriumfluoralkoholaten. | |
| PT84130A (fr) | Procede de preparation de nouveaux derives de 3-alkoxyflavones et de leurs compositions therapeutiques | |
| IE821049L (en) | Aminocyclitol derivatives | |
| PT80686A (de) | Verfahren zur herstellung von mehrlagenleiterplatten nach diesem verfahren hergestellter fixierter langenaufbaus bei diesen herstellungsverfahren | |
| FI884732A7 (fi) | Menetelmä jalostamattomien polyorganofosfatseenien, jotka on valmistettu kosubstituoimalla polydikloorifosfatseeneja, puhdistamiseksi | |
| PT80531A (de) | Verfahren zur herstellung acylerter zuckerderivate | |
| DE68917379D1 (de) | Verfahren zur Herstellung von Proteinen, die ähnlich dem natürlich-menschlichen Apolipoprotein-E sind. | |
| ES546136A0 (es) | Proceso para producir derivados de 1,4-dihidro-piridina-3,5,dicarboxilato. | |
| DE69113772D1 (de) | 1,4-benzodioxanderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen. | |
| ATE20478T1 (de) | Heteroglucan, verfahren zu dessen herstellung und es enthaltender immunologischer aktivator. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19921216 |
|
| PG1501 | Laying open of application | ||
| PC1203 | Withdrawal of no request for examination | ||
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |